Gollob Jared (CIK 1821198) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-04). Recent activity: Sell KYMR (1,510 shares), Buy KYMR (17,650 shares), Sell KYMR (1,055 shares), Sell KYMR (3,048 shares), Sell KYMR (492 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 1,510 | $132,502 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 17,650 | $0 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 1,055 | $93,368 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 3,048 | $273,284 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 492 | $41,328 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 2,519 | $214,216 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 1,437 | $123,266 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 447 | $38,719 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 8,562 | $771,607 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 13,759 | $1.2M |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 18,357 | $1.6M |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 3,929 | $351,370 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 49,307 | $262,806 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 3,300 | $301,818 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 1,400 | $129,066 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 28,999 | $37,989 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 22,210 | $46,197 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 8,963 | $551,135 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 14,896 | $934,277 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 6,453 | $407,120 |
| 2025-10-15 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 29,264 | $1.8M |
| 2025-10-14 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 800 | $1,048 |
| 2025-10-14 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 673 | $1,400 |
| 2025-10-14 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Sell | 3,114 | $186,840 |
| 2025-03-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-04